Cargando…
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
Kryptofix(®) 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in (18)F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit conc...
Autores principales: | Kuntzsch, Matthias, Lamparter, Denis, Brüggener, Nils, Müller, Marco, Kienzle, Gabriele J., Reischl, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035771/ https://www.ncbi.nlm.nih.gov/pubmed/24830987 http://dx.doi.org/10.3390/ph7050621 |
Ejemplares similares
-
Quick Automatic Synthesis of Solvent-Free 16α-[(18)F] Fluoroestradiol: Comparison of Kryptofix 222 and Tetrabutylammonium Bicarbonate
por: Jiang, Xiao, et al.
Publicado: (2020) -
A Fast and Simple Method for the Determination of TBA in (18)F-Labeled Radiopharmaceuticals
por: Halvorsen, Nils Erik, et al.
Publicado: (2020) -
Special Issue “Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine”
por: Reischl, Gerald
Publicado: (2019) -
Impact of Tetrabutylammonium on the Oxidation of Bromide
by Ozone
por: Chen, Shuzhen, et al.
Publicado: (2021) -
TLC–Densitometry for Determination of Omeprazole in Simple and Combined Pharmaceutical Preparations
por: Parys, Wioletta, et al.
Publicado: (2022)